AstraZeneca Unveils AI-Powered Research and Development Platform
agents
| Source: ArXiv | Original article
AstraZeneca develops AI system to aid R&D. The system assists scientists with biomedical queries.
AstraZeneca has developed Research Assistant, an internal system leveraging Large Language Models (LLMs) to aid scientists and clinicians in exploring biomedical questions. This system offers a chat-style interface, aggregating information from a wide range of data sources.
As we have seen in recent developments, such as the Diagnostic Foundation for Evaluating LLMs' Research Integrity, there is a growing interest in harnessing AI for research purposes. AstraZeneca's move underscores the potential of LLMs in streamlining R&D processes, particularly in the pharmaceutical sector.
What to watch next is how Research Assistant will be integrated into AstraZeneca's existing R&D framework and its potential impact on the discovery of new treatments and therapies. This development could also prompt other pharmaceutical companies to explore similar AI-driven solutions, potentially transforming the industry's approach to research and development.
Sources
Back to AIPULSEN